Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and...
6 insider purchases on record · latest filing 2021-02-09.
Insiders have also filed 94 sale transactions at VOR.